# Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months

> **NCT07505810** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 880 (estimated)

## Conditions studied

- Epidemic Meningitis
- Meningococcal Vaccines

## Interventions

- **BIOLOGICAL:** experimental vaccine
- **BIOLOGICAL:** Active Comparator vaccine

## Key facts

- **NCT ID:** NCT07505810
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-22
- **Primary completion:** 2027-04
- **Final completion:** 2028-01
- **Target enrollment:** 880 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07505810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07505810, "Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07505810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*